Eiger Has Positive Data For Its COVID-19 Drug, But Faces Uncertain Market

 
• By Alaric DeArment
3D_Coronavirus
Eiger announced data from its Phase III trial of peginterferon lambda in non-hospitalized COVID-19 patients. • Source: Shutterstock

More from COVID-19

More from Scrip